Absence of transaminase elevation during concomitant methotrexate and isoniazid therapy.
Ekochin
Lea Hilda
LH
Manadan
Augustine M
AM
Aggarwal
Rohit
R
Sequeira
Winston
W
Block
Joel A
JA
D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D012189:Retrospective Studies; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy*; D000637:Transaminases / Q000378:metabolism*; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*
D018501:Antirheumatic Agents; D000995:Antitubercular Agents; D000637:Transaminases; D007538:Isoniazid; D008727:Methotrexate